News and Trends 11 Jun 2018 Danish Biotech Plans Phase II Study to Fight A Rare Eating Disorder …a range of treatments targeting other indications, including type 2 diabetes, cocaine addiction and Parkinson’s disease. Last year, the company started a Phase III trial for Tesofine, the most advanced… June 11, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Jul 2025 10 biotech companies leading the way in Denmark …neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease. The company was formed as a result of the combination of two European startup companies: Muna and K5 Therapeutics. Muna’s portfolio of disease-modifying… July 29, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2017 Mind the Gut: Copenhagen Exhibition Explores Bacteria and Feelings …in our gut and our mind. Scientists have drawn links between the bacteria living inside us and mental conditions such as depression, anxiety, schizophrenia and Parkinson’s. Left: electric machine for… October 7, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 31 Aug 2022 Anti-cancer drug created from reprogrammed yeast …malaria, and Parkinson’s disease. Producing medications otherwise sourced from plants in industrial-scale fermenters using cheap and renewable substrates may alleviate future shortages and create a more sustainable economy independent of… August 31, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jan 2018 Swiss Biotech Gets $339M to Boost the Development of Drug Addiction Therapies …up by around 24%. Addex has been around for a while now, focusing on diseases like Parkinson’s and epilepsy as well as drug addiction. However, the development of drugs in… January 3, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 12 Mar 2018 A Flick of a Switch Can Cause Age-Related Brain Deterioration …the market. Synpromics teamed up with University College London to develop gene therapies for Parkinson’s and this news could help it to tackle other conditions. By identifying a role for… March 12, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 15 Feb 2017 Optogenetics: What Makes It a Powerful Neuroscience Tool? …a therapy for neurological diseases like epilepsy or Parkinson’s. Neurons can be easily controlled using a method that is fast, with responses at the millisecond scale, reversible and cell specific…. February 15, 2017 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 19 May 2023 Google Cloud adds AI solutions for drug discovery …the brain to solve some of the most difficult to treat neuroscience diseases, including evaluating novel therapies for schizophrenia, epilepsy, and Parkinson’s disease. The Target and Lead Identification Suite with… May 19, 2023 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2017 Galapagos finds a Partner to Boost its Pipeline with Drug Combinations …Parkinson’s and amyotrophic lateral sclerosis (ALS). “Pharnext has already obtained promising clinical results with its cutting-edge technology, which has encouraged us to collaborate,” explained Onno van de Stolpe, CEO of… March 10, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 19 Sep 2017 Scottish Scientists Claim that the Genome Controls the Aging of the Brain …could be overridden, could age-related diseases such as Alzheimer’s and Parkinson’s be prevented? In July, a group from the University of Sheffield published findings that identified a gene mutation responsible… September 19, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Top biotech grants and campaigns …Society of America Michael J. Fox Foundation for Parkinson’s Research Tourette Association of America Oncology American Cancer Society Breast Cancer Research Foundation Cancer Research UK Leukemia & Lymphoma Society Ludwig… June 20, 2024 - 2 minutesmins - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
News and Trends 17 Nov 2016 UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy …stage. Meanwhile, the programs focusing on Sanfilippo B and Parkinson’s will be left behind and possibly discontinued or licensed out. UniQure expects this move will save it up to €15M… November 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email